What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Klaus J. Busam focuses on Pathology, Melanoma, Immunohistochemistry, Nevus and Cancer research.
Klaus J. Busam usually deals with Pathology and limits it to topics linked to Fluorescence in situ hybridization and Biopsy and Gene rearrangement.
His Melanoma research is multidisciplinary, incorporating elements of Cancer, Metastasis, Melanocyte differentiation and Neuroblastoma RAS viral oncogene homolog.
His Immunohistochemistry study incorporates themes from Oral mucosa, Monoclonal antibody, Antigen and MART-1 Antigen.
His study in Nevus is interdisciplinary in nature, drawing from both Entrectinib, Kinase and Base sequence.
His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, GNA11, Carcinogenesis and Exon.
His most cited work include:
- Distinct Sets of Genetic Alterations in Melanoma (2055 citations)
- Somatic Activation of KIT in Distinct Subtypes of Melanoma (1221 citations)
- Mutations in GNA11 in Uveal Melanoma (919 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Melanoma, Pathology, Dermatology, Immunohistochemistry and Nevus.
The subject of his Melanoma research is within the realm of Cancer research.
His Cancer research study combines topics in areas such as Mutation and Neuroblastoma RAS viral oncogene homolog.
His studies deal with areas such as Fluorescence in situ hybridization and Melanocytic nevus as well as Pathology.
His Dermatology study integrates concerns from other disciplines, such as Lentigo maligna and Spitz nevus.
Klaus J. Busam has included themes like Sentinel lymph node and Lesion in his Biopsy study.
He most often published in these fields:
- Melanoma (48.40%)
- Pathology (48.13%)
- Dermatology (23.26%)
What were the highlights of his more recent work (between 2018-2021)?
- Melanoma (48.40%)
- Pathology (48.13%)
- Dermatology (23.26%)
In recent papers he was focusing on the following fields of study:
Klaus J. Busam spends much of his time researching Melanoma, Pathology, Dermatology, Cancer research and Immunohistochemistry.
His research integrates issues of Biopsy and Metastasis in his study of Melanoma.
The various areas that Klaus J. Busam examines in his Pathology study include Melanocytoma, Fluorescence in situ hybridization and Head and neck.
His Cancer research research integrates issues from Cancer/testis antigens and Neuroblastoma RAS viral oncogene homolog.
His Immunohistochemistry study combines topics from a wide range of disciplines, such as PRAME and Antigen.
His Antigen research is multidisciplinary, relying on both Antibody and Monoclonal antibody.
Between 2018 and 2021, his most popular works were:
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. (354 citations)
- Filigree-like Rete Ridges, Lobulated Nests, Rosette-like Structures, and Exaggerated Maturation Characterize Spitz Tumors With NTRK1 Fusion. (19 citations)
- Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma. (15 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Klaus J. Busam mainly focuses on Melanoma, Pathology, Lentigo maligna, Nevus and Lentigo maligna melanoma.
His Melanoma study deals with the bigger picture of Cancer research.
His biological study focuses on Immunohistochemistry.
His work in Lentigo maligna addresses subjects such as Dermatology, which are connected to disciplines such as Melanoma in situ, Germline and Dermatoscopy.
Klaus J. Busam interconnects Karyotype, SNP array, Chromosome 3 and Loss of heterozygosity in the investigation of issues within Nevus.
His Lentigo maligna melanoma research includes themes of Treatment options, Biopsy, Retrospective cohort study and Hair follicle.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
